With COVID-19 shots finally available for infants and preschoolers, knowing how to combat misinformation on social media and elsewhere could be more important than ever.
Rigor académico, oficio periodístico
Artículos sobre Vaccine safety
Mostrando 1 - 20 de 42 artículos
Contrary to the popular belief that social media creates rumours about COVID vaccine harms, new research suggests social media generally only aids the spread of these rumours.
A panel of experts answer questions about vaccines, omicron and other COVID-related issues in a discussion with The Conversation.
Pediatricians and other health care providers can take some concrete steps toward building trust and counteracting anti-vaccination misinformation.
To help increase trust in vaccines, researchers analyzed data on adverse events to address safety concerns, and then used cognitive science to show how cognitive biases feed vaccine hesitancy.
A survey found almost a quarter of participants thought they could not receive a vaccine because of medical conditions. But only 28.9% of this group actually meet the criteria set by health agencies.
Australia is now rolling out the Pfizer vaccine to people aged under 50, with the 40-49 age group newly eligible. Here’s what you can expect.
The TGA has reported a handful of cases of the autoimmune disorder Guillain-Barré syndrome following the AstraZeneca vaccine.
Many people are unsure if their condition qualifies as an underlying medical condition. They may not realise they’re already eligible for the COVID vaccine.
A serious event such as a blood clot could be caused by an underlying medical condition, a medication the person was taking at the time, or some other factor unrelated to the vaccine.
Both the AstraZeneca and Johnson & Johnson vaccines are now being investigated for links to rare blood disorders.
European regulators are investigating a possible link between the vaccine and a second rare blood disorder.
The challenge now is to address the understandable concerns and prevent them from contaminating the broader public dialogue on COVID-19 vaccination.
All vaccines and medications come with risks. But the risks of delaying vaccination are far higher.
Vaccine manufacturing is complex, with lots of potential points for errors. But it also has extensive quality control checks and approvals.
Many people never experience the least bit of discomfort from the COVID-19 vaccines, but mild side effects are common. They include swelling in the affected arm, nausea and chills.
So far, most vaccines in the US are mRNA vaccines. These represent a new technology and are likely to take over the vaccine world. But how do they work? What are their weaknesses? Five experts explain.
Vaccination has been controversial from its beginning. Gaining people’s trust in vaccines has been crucial. An important part of that is a strong communications plan.
Years of vaccine research tells us that, if side effects are going to occur, they normally occur within the first months after getting a vaccine.
How will governments convince enough people to get vaccinated to achieve herd immunity?
Principales colaboradores
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Postdoctoral Associate in Behavioral and Community Health Sciences, University of Pittsburgh
-
Professor, Susan Wakil School of Nursing and Midwifery, University of Sydney
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Assistant Professor of Pediatrics, University of Pittsburgh
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Assistant Professor of Political Science, Oklahoma State University
-
Assistant Professor of Public Health, University of Pittsburgh
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Professor of Medicine, University of Virginia
-
Assistant Professor of Sociology, Psychology, and Public Health, University of Nottingham
-
Director, Center for Public Interest Communications, University of Florida
-
Professor of Pharmacy Practice, Drake University
-
Professor and Eugene M. Isenberg Chair in Integrative Studies, UMass Amherst
-
Professor of Public Health and Law, Indiana University
